EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)

Defense

Contracts and/or supply of the military for stockpiling and use of medical countermeasures including anthrax vaccine, IVIG, AIGIV, BIGIV, and chemical WMD decontamination and neutralization lotion (RSDL).

TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Joint Chiefs of Staff · Air Force, Dept of · Army, Dept of (Other) · Health & Human Services, Dept of (HHS) · Defense Logistics Agency · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Natl Institutes of Health (NIH) · Homeland Security, Dept of (DHS) · Defense Threat Reduction Agency (DTRA)

Homeland Security

Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,

TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Joint Chiefs of Staff · Air Force, Dept of · Army, Dept of (Other) · Health & Human Services, Dept of (HHS) · Defense Logistics Agency · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Natl Institutes of Health (NIH) · Homeland Security, Dept of (DHS) · Defense Threat Reduction Agency (DTRA)